Joseph F. Mazzella
Known title: DirectorCIK: 0001196045
Associated companies
Transaction History
| PFSI | ▲ Buy | Grant | 359 | $33K | 5/7/2026 | View on chart |
| PFSI | ▲ Buy | Grant | 226 | $33K | 2/2/2026 | View on chart |
| PFSI | ▼ Sell | Gift | 5,000 | $0 | 12/22/2025 | View on chart |
| PFSI | ▲ Buy | Grant | 270 | $31K | 10/23/2025 | View on chart |
| PFSI | ▼ Sell | Open Market | 7,107 | $769K | 8/13/2025 | View on chart |
| PFSI | ▲ Buy | Grant | 294 | $30K | 7/24/2025 | View on chart |
| PFSI | ▲ Buy | Grant | 304 | $30K | 5/2/2025 | View on chart |
| PFSI | ▼ Sell | Open Market | 9,376 | $920K | 5/2/2025 | View on chart |
| PFSI | ▼ Sell | Open Market | 1,624 | $160K | 5/2/2025 | View on chart |
| PFSI | ▲ Buy | Grant | 1,547 | $0 | 2/14/2025 | View on chart |
| PFSI | ▲ Buy | Grant | 292 | $30K | 2/5/2025 | View on chart |
| PFSI | ▼ Sell | Gift | 4,000 | $0 | 12/30/2024 | View on chart |
| PFSI | ▲ Buy | Grant | 274 | $30K | 12/20/2024 | View on chart |
| PFSI | ▼ Sell | Open Market | 11,396 | $1.1M | 8/14/2024 | View on chart |
| PFSI | ▲ Buy | Grant | 296 | $30K | 7/25/2024 | View on chart |
| PFSI | ▼ Sell | Open Market | 16,465 | $1.5M | 5/3/2024 | View on chart |
| PFSI | ▲ Buy | Grant | 337 | $30K | 4/26/2024 | View on chart |
| PFSI | ▲ Buy | Grant | 1,854 | $0 | 2/29/2024 | View on chart |
| PFSI | ▲ Buy | Grant | 342 | $30K | 2/5/2024 | View on chart |
| PFSI | ▼ Sell | Gift | 9,000 | $0 | 12/21/2023 | View on chart |
| PFSI | ▼ Sell | Open Market | 12,000 | $1.1M | 12/18/2023 | View on chart |
| PFSI | ▲ Buy | Grant | 770 | $62K | 12/8/2023 | View on chart |
| PFSI | ▲ Buy | Grant | 421 | $27K | 5/1/2023 | View on chart |
| PFSI | ▲ Buy | Grant | 2,387 | $0 | 2/24/2023 | View on chart |
| PFSI | ▲ Buy | Grant | 421 | $27K | 2/6/2023 | View on chart |
| PFSI | ▼ Sell | Open Market | 40,000 | $2.3M | 12/14/2022 | View on chart |
| PFSI | ▼ Sell | Open Market | 30,000 | $1.7M | 12/12/2022 | View on chart |
| PFSI | ▲ Buy | Grant | 588 | $27K | 10/31/2022 | View on chart |
| PFSI | ▼ Sell | Open Market | 13,000 | $713K | 9/15/2022 | View on chart |
| PFSI | ▼ Sell | Open Market | 7,000 | $384K | 9/15/2022 | View on chart |
| PFSI | ▼ Sell | Open Market | 7,000 | $409K | 8/15/2022 | View on chart |
| PFSI | ▼ Sell | Open Market | 13,000 | $760K | 8/15/2022 | View on chart |
| PFSI | ▲ Buy | Grant | 560 | $27K | 8/4/2022 | View on chart |
| PFSI | ▼ Sell | Open Market | 11,705 | $589K | 7/20/2022 | View on chart |
| PFSI | ▼ Sell | Open Market | 6,303 | $317K | 7/20/2022 | View on chart |
| PFSI | ▼ Sell | Open Market | 14,295 | $716K | 7/19/2022 | View on chart |
| PFSI | ▼ Sell | Open Market | 7,697 | $386K | 7/19/2022 | View on chart |
| PFSI | ▼ Sell | Open Market | 13,000 | $652K | 5/26/2022 | View on chart |
| PFSI | ▼ Sell | Open Market | 7,000 | $351K | 5/26/2022 | View on chart |
| PFSI | ▲ Buy | Grant | 556 | $27K | 5/9/2022 | View on chart |
| PFSI | ▲ Buy | Grant | 2,539 | $0 | 2/23/2022 | View on chart |
| PFSI | ▼ Sell | Open Market | 1,752 | $108K | 2/11/2022 | View on chart |
| PFSI | ▼ Sell | Open Market | 23,248 | $1.4M | 2/11/2022 | View on chart |
| PFSI | ▲ Buy | Grant | 381 | $27K | 2/7/2022 | View on chart |
| PFSI | ▼ Sell | Gift | 6,000 | $0 | 12/20/2021 | View on chart |
| PFSI | ▲ Buy | Grant | 372 | $25K | 11/8/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
BTIG Lowers PennyMac Financial Price Target to $80
BTIG maintained its positive stance on PennyMac Financial but lowered its price target to $80. This move occurs as the stock trades near its support level, reflecting a cautious outlook from analysts. The company's valuation remains low relative to peers, with a trailing P/E of 7.9.
BTIG Lowers PennyMac Financial Price Target to $80. BTIG maintained its positive stance on PennyMac Financial but lowered its price target to $80. This move occurs as the stock trades near its support level, reflecting a cautious outlook from analysts. The company's valuation remains low relative to peers, with a trailing P/E of 7.9.